SLRX

SLRX

Salarius Pharmaceuticals Inc. Common Stock

$0.707+-0.000 (-0.000%)

Preço em tempo real

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$0.707

Máximo

$0.707

Mínimo

$0.707

Volume

0.07M

Fundamentos da empresa

Estatísticas de negociação

Notícias relacionadas

GlobeNewswire

Salarius Pharmaceuticals Merger Partner, Decoy Therapeutics, Announces its Novel Inhibitors Show Promising In Silico Activity Against Measles and Related Viruses

CAMBRIDGE, Mass. and HOUSTON, March 26, 2025 (GLOBE NEWSWIRE) -- Decoy Therapeutics Inc. (Decoy), a privately held preclinical biopharmaceutical company engineering the next generation of peptide-conjugate

Ver mais
Salarius Pharmaceuticals Merger Partner, Decoy Therapeutics, Announces its Novel Inhibitors Show Promising In Silico Activity Against Measles and Related Viruses
GlobeNewswire

Salarius Pharmaceuticals Reports 2024 Financial Results and Provides Business Update

Contemplated merger with Decoy Therapeutics progressing as planned; upon closing, combined company expected to accelerate clinical development of novel peptide conjugate therapeutics for treating respiratory viruses and

Ver mais
Salarius Pharmaceuticals Reports 2024 Financial Results and Provides Business Update